CXCL9 and breast carcinoma: In breast cancer,tumor cell expression of the chemokines CXCL9 and 10 recruits lymphocytes, improvessurvival in mouse models and human studies [29,30], and PGE2 inhibits expression of both chemokines in breastcancer cells in vitro [12].